A comparative analysis reveals the dosage sensitivity and regulatory patterns of lncRNA in prostate cancer. Issue 10 (10th August 2016)

• Record Type: Journal Article
• Authors: Liu, Yongjing; Zhang, Rui; Zhao, Ning; Zhang, Qiang; Yan, Zichuang; Chang, Zhiqiang; Wei, Yunzhen; Wu, Cheng; Xu, Jin; Xu, Yan
• Is Part Of: Molecular bioSystems. Volume 12:Issue 10(2016:Oct.)
• Page Start: 3176
• Page End: 3185
• Publication Date: 2016-08-10
• Subjects: Molecular biology -- Periodicals; Biochemistry -- Periodicals; 571.7405
• DOI: 10.1039/c6mb00359a
• Languages: English
• ISSNs: 1742-206X

Abstract

Abstract : Although the key roles of long non-coding RNAs (lncRNAs) in multiple diseases are well documented, the relationship between the lncRNA copy number and expression is unknown. Abstract : Although the key roles of long non-coding RNAs (lncRNAs) in multiple diseases are well documented, the relationship between the lncRNA copy number and expression is unknown. Here, we present a comprehensive study that demonstrates the impact of miRNA-TF co-regulatory motifs on the dosage effects of protein-coding genes (PCGs) and lncRNAs in prostate cancer. By integrating copy number profiles, expression profiles and regulatory relationships with miRNAs and transcription factors, we reveal that lncRNAs and PCGs correlate with distinct dosage sensitivity and regulatory pattern characteristics. We also show that lncRNAs from different genomic regions have different features. Using a custom-built framework, we identified 24 candidate prostate cancer-related lncRNAs based on the known properties of established prostate-related lncRNAs. Our method will enable the identification of cancer-related lncRNAs, which will provide new insights into cancer lncRNA biology.